125 related articles for article (PubMed ID: 31313936)
1. The Expression of MBD6 Is Associated with Tumor Size in Uterine Leiomyomas.
Liang MR; Zeng Y; Zeng SY; Zhang JW; Yang BC; Zhang ZY; Liu FY; Luo Y; Zou Y; Wang F; Huang OP
Genet Test Mol Biomarkers; 2019 Aug; 23(8):523-532. PubMed ID: 31313936
[No Abstract] [Full Text] [Related]
2. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
3. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
4. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
5. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
7. An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas.
Cirilo PD; Marchi FA; Barros Filho Mde C; Rocha RM; Domingues MA; Jurisica I; Pontes A; Rogatto SR
PLoS One; 2013; 8(3):e57901. PubMed ID: 23483937
[TBL] [Abstract][Full Text] [Related]
8. The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA.
Laget S; Joulie M; Le Masson F; Sasai N; Christians E; Pradhan S; Roberts RJ; Defossez PA
PLoS One; 2010 Aug; 5(8):e11982. PubMed ID: 20700456
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
13. A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.
Delaney MA; Wan YW; Kim GE; Creighton CJ; Taylor MG; Masand R; Park A; Valdes C; Gibbons W; Liu Z; Anderson ML
J Clin Endocrinol Metab; 2017 Sep; 102(9):3316-3326. PubMed ID: 28637297
[TBL] [Abstract][Full Text] [Related]
14. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
17. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
18. DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma.
Li S; Chiang TC; Richard-Davis G; Barrett JC; Mclachlan JA
Gynecol Oncol; 2003 Jul; 90(1):123-30. PubMed ID: 12821352
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Uterine Fibroid Etiology.
McWilliams MM; Chennathukuzhi VM
Semin Reprod Med; 2017 Mar; 35(2):181-189. PubMed ID: 28278535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
